Inhibition of lymphocyte-specific enzymes: a promising approach for selective immunosuppression.
Ruers
T J
TJ
Department of Surgery, University of Limburg, Maastricht, The Netherlands.
Buurman
W A
WA
van der Linden
C J
CJ
Kootstra
G
G
D058892:Adenosine Deaminase Inhibitors; D002478:Cells, Cultured; D004261:DNA Replication / Q000187:drug effects; D003839:Deoxyadenosines / Q000494:pharmacology*; D006801:Humans; D007165:Immunosuppression Therapy; D007376:Interleukin-2 / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology / Q000276:immunology*; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D015649:Pentostatin / Q000494:pharmacology*
D058892:Adenosine Deaminase Inhibitors; D003839:Deoxyadenosines; D007376:Interleukin-2; D015649:Pentostatin; D009700:Nucleoside Deaminases